Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders

Gastroenterology

Volumn 118, Issue 4, 2000, Pages 655-660

  Nelson, David R ^a   Lauwers, Gregory Y ^a   Lau, Johnson Y N ^b   Davis, Gary L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; RECOMBINANT INTERLEUKIN 10;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 0034022483     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70134-X     Document Type: Article

References (25)

1. MJ Tong, NS el-Farra, AR Reikes, and RL. Co Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
2. SC Darby, DW Ewart, PFL Giangrande, RJ Spooner, CR Rizza, GM Dusheiko, CA Lee, CA Ludlam, and FE. Preston Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C Lancet 350 1997 1425 1431
3. National Institutes of Health National Institutes of Health Concensus Development Conference Panel statement: management of hepatitis C Hepatology 26 suppl 1 1997 2S 10S
4. DF Fiorentino, A Zlotnick, TR Mosmann, M Howard, and A. O'Garra IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells J Immunol 146 1991 3444 3451
5. DR Nelson, and JYN. Lau Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection Clin Liver Dis 1 1997 515 527
6. H Tilg, A Wilmer, W Vogel, M Herold, B Nolchen, G Judmaier, and C. Huber Serum levels of cytokines in chronic liver diseases Gastroenterology 103 1992 264 274
7. DR Nelson, HL Lim, CG Marousis, JW Fang, GL Davis, L Shen, MS Urdea, JA Kolberg, and JY. Lau Activation of tumor necrosis- system in chronic hepatitis C virus infection Dig Dis Sci 42 1997 2487 2494
8. J Napoli, A Bishop, PH McGuinness, DM Painter, and GW. McCaughan Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cyto-kines Hepatology 24 1996 759 765
9. T Arai, K Hiromatsu, N Kobayashi, M Takano, H Ishida, Y Nimura, and Y. Yoshikai IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver disease J Immunol 155 1995 5743 5749
10. H Louis, O Le Moine, M-O Peny, E Quertinmont, D Fokan, M Goldman, and J. Deviere Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice Hepatology 25 1997 1382 1389
11. M Nagaki, M Tanaka, A Sugiyama, H Ohnishi, and H. Moriwaki Interleukin-10 inhibits hepatic injury and tumor necrosis factor- and interferon-γ mRNA expression induced by staphylococcal enterotoxin B or lipopolysacharide in galactosamine-sensitized mice J Hepatol 31 1999 815 824
12. GL Davis, JYN Lau, MS Urdea, PD Neuwald, JC Wilber, K Lindsay, RP Perrillo, and J. Albrecht Quantitative detection of hepatitis C virus RNA by a solid-phase signal amplification method. Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients Hepatology 19 1994 1337 1341
13. JYN Lau, GL Davis, ME Brunson, KP Qian, HJ Lin, S Quan, R DiNello, AJ Polito, and JC. Scornik Hepatitis C virus infection in renal transplant recipients Hepatology 18 1993 1027 1031
14. P Simmonds, EC Holmes, TA Cha, SW Chan, F McOmish, B Irvine, E Beall, PL Yap, J Kolberg, and MS. Urdea Classification of hepatitis C into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region J Gen Virol 74 1993 2391 2399
15. + T-cell activity in PBMC JYN Lau, Methods in molecular medicine. Volume 19 1998 Humana Totowa, NJ 413 422 Hepatitis C protocols
16. DR Nelson, CG Marousis, GL Davis, CM Rice, J Wong, M Houghton, and JY. Lau The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C J Immunol 158 1997 1473 1481
17. C. Taswell Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model J Immunol Methods 72 1984 29 40
18. K Ishak, A Baptista, L Bianchi, F Callea, J DeGroot, F Gudat, H Denk, V Desmet, G Korb, and RN. MacSween Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
19. JG McHutchinson, SC Gordon, ER Schiff, ML Shiffman, WM Lee, VK Rustgi, ZD Goodman, MH Ling, S Cort, and JK. Albrecht Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 339 1998 1458 1492
20. T Poynard, P Marcellin, S Lee, C Niederau, GS Minuk, G Ideo, V Bain, J Heathcote, S Zeuzem, C Trepo, and J. Albrecht Randomized trial of interferon alfa-2b and ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic hepatitis C virus Lancet 352 1998 1426 1432
21. T Poynard, P Bedossa, M Chevallier, P Mathurin, C Lemonnier, C Trepo, P Couzigou, JL Payen, M Sajus, and JM. Costa A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis N Engl J Med 332 1995 1457 1462
22. SC Wang, M Ohata, L Schrum, RA Rippe, and H. Tsukamoto Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells J Biol Chem 273 1998 302 308
23. S Reitamo, A Remitz, K Tamai, and J. Uitto Interleukin 10 modulates type 1 collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts J Clin Invest 94 1994 2489 2492
24. H Louis, O Le Moine, M-O Peny, E Quertinmont, D Fokan, M Goldman, and J. Deviere Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice Hepatology 25 1997 1382 1389
25. K Thompson, J Maltby, J Fallowfield, M Mcaulay, H Millward-Sadler, and N. Sheron Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis Hepatology 28 1998 1597 1606